SEARCH

SEARCH BY CITATION

Reference

  • 1
    Nouri AME, Panayi GS, Goodman SM: Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 55: 295302, 1984
  • 2
    Wood DD, Ihrie EJ, Dinarello CA, Cohen PL: Isolation of an interleukin-1–like factor from human joint effusions. Arthritis Rheum 26: 975983, 1983
  • 3
    Hopkins SJ, Humphreys M, Jayson MIV: Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 72: 422427, 1988
  • 4
    Smith JB, Bocchieri MH, Sherbin-Allen L, Borogsky M, Abruzzo JL: Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay inhibiting factors. Rheumatol Int 9: 5358, 1989
  • 5
    MacNaul KL, Hutchinson NI, Parsons JN, Bayne EK, Tocci MJ: Analysis of IL-1 and TNFδ gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J Immunol 145: 41544166, 1990
  • 6
    Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M: Interleukin-1 and tumor necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1δ. Clin Exp Immunol 73: 449455, 1988
  • 7
    Eastgate JA, Symons JA, Wood NC, Grinlinton FM, diGiovine FS, Duff GW: Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet II: 706709, 1988
  • 8
    Dingle JT, Page Thomas DP, King B, Bard DR: In vivo studies of articular tissue damage mediated by catabolin/interleukin-1. Ann Rheum Dis 46: 527533, 1987
  • 9
    Pettipher ER, Higgs GA, Henderson B: Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A 83: 87498753, 1986
  • 10
    Van de Loo AAJ, van Beuningen HM, van Lent PL, van den Berg WB: Direct effects of murine rIL-1 on cartilage metabolism in vivo. Agents Actions 26: 153155, 1989
  • 11
    Hom JT, Bendele AM, Carlson DG: In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol 141: 834841, 1988
  • 12
    Killar LM, Dunn CJ: Interleukin-1 potentiates the development of collagen-induced arthritis in mice. Clin Sci 76: 535538, 1989
  • 13
    Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH: Exacerbation of arthritis by IL-1 in joints previously injured by peptidoglycan-polysaccharide. J Immunol 140: 29642969, 1988
  • 14
    Staite ND, Richard KA, Aspar DG, Franz KA, Galinet LA, Dunn CJ: Induction of an acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin. Arthritis Rheum 33: 253260, 1990
  • 15
    Schwab JH, Anderle SK, Brown RR, Dalldorf FG, Thompson RC: Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun 59: 44364442, 1991
  • 16
    Van de Loo FA, Arntz OJ, Otterness IG, Van denBerg WB: Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 19: 348356, 1992
  • 17
    Arend WP, Joslin FG, Massoni RJ: Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol 134: 38683875, 1985
  • 18
    Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 342: 341346, 1990
  • 19
    Carter DB, Deibel MR, Dunn CJ, Tomich C-SC, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PKW, Yem AW, Waszak GA, Chosay JG, Siev LC, Hardee MM, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Truesdell SE, Shelly JA, Eessalu TE, Taylor BM, Tracey DE: Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344: 633638, 1990
  • 20
    Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DG, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343: 336340, 1990
  • 21
    Cremer MA, Stuart JM, Townes AS, Kang AH: Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol 124: 29122918, 1980
  • 22
    Brackertz D, Mitchell GF, Mackay IR: Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 20: 841850, 1977
  • 23
    Hunneyball M, Crossley MJ, Spowage M: Pharmacological studies of antigen-induced arthritis in Balb/c mice. I. Characterization of the arthritis and the effects of steroidal and non-steroidal anti-inflammatory agents. Agents Actions 18: 384393, 1986
  • 24
    Wooley PH, Luthra HS, Stuart JM, David CS: Type II collagen-induced arthritis in mice. I. MHC (I-region) linkage and antibody correlates. J Exp Med 154: 688700, 1981
  • 25
    Wooley PH, Whalen JD, Warner LM, Losten MK, Chapdelaine JM: Type II collagen-induced arthritis in mice. V. The role of spleen cell response in the immune and arthritogenic reaction to type II collagen. J Rheumatol 16: 11921196, 1989
  • 26
    Bienkowski MJ, Eessalu TE, Berger AE, Truesdell SE, Shelly JA, Laborde AL, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Chosay JG, Tracey DE: Purification and characterization of IL-1 receptor level antagonist proteins from THP-1 cells. J Biol Chem 265: 1450514511, 1990
  • 27
    Alexander RH, Doherty GM, Buresh CM, Venzon DJ, Norton JA: A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. J Exp Med 173: 10291032, 1991
  • 28
    McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Killian PL: Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173: 931939, 1991
  • 29
    Hunneyball IM, Crossley MJ, Spowage M: Pharmacological studies of antigen-induced arthritis in Balb/c mice. II. The effects of second-line anti-rheumatic drugs and cytotoxic agents on the histopathological changes. Agents Actions 18: 394400, 1986
  • 30
    Blackham A, Griffiths RJ: The effect of FK506 and cyclosporin-A on antigen-induced arthritis. Clin Exp Immunol 86: 224228, 1991
  • 31
    Hom JT, Gliszczynski VL, Cole HW, Bendele AM: Interleukin-1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs. Agents Actions 33: 300309, 1991
  • 32
    Jacobs C, Young D, Tyler S, Callis G, Gillis S, Conlon P: In vivo treatment with IL-1 reduces the severity and duration of antigen-induced arthritis in rats. J Immunol 141: 29672974, 1988
  • 33
    Nakamura H, Motoyoshi S, Kadokawa T: Anti-inflammatory action of interleukin-1 through the pituitary-adrenal axis in rats. Eur J Pharmacol 151: 6773, 1988
  • 34
    Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149: 10541062, 1992
  • 35
    Malyak M, Joslin FG, Verderber EL, Eisenberg SP, Arend WP: IL-1ra ELISA, reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors. J Immunol Methods 140: 281288, 1991
  • 36
    Lotz M, Tsoukas CD, Robinson CA, Dinarello CA, Carson DA, Vaughan JH: Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies. J Clin Invest 78: 713721, 1986
  • 37
    Symons JA, Eastgate JA, Shaw A, Duff GW: Identification and preliminary characterization of a specific interleukin-1b̃ binding protein (abstract). Cytokine 1: 93, 1989
  • 38
    Symons JA, Duff GW: A soluble form of the interleukin-1 receptor produced by a human B-cell line. FEBS Lett 272: 133136, 1990
  • 39
    Suzuki H, Akama T, Okane M, Kono I, Matsui Y, Yamane K, Kashiwagi H: Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis. Arthritis Rheum 32: 15281538, 1989
  • 40
    Higgins GC, Postlethwaite AE: A synovial fluid inhibitor specifically binds IL-1δ (abstract). Arthritis Rheum 33 (suppl 9): S20, 1990